Related to Transgenomic Licenses Cold-PCR Technology from the Dana-Farber Cancer Institute

• Optimata and Teva to Repurpose Shelved Cancer Drug Candidates
  
• Morphotek Taps Synageva in Cancer and Infectious Disease Deal
  
• Repros Gets an Extension from NIH for Deadlines Related to Lead Anticancer Agent
  
• DxS and Epigenomics Cross-License Technologies for DNA Methylation In Vitro Diagnostics
  
• OSI to Pay $20M to Broaden Cancer Partnership with AVEO
  
• GSK and Enigma to Develop Point-of-Care Flu Diagnostic
  
• BioFocus DPI and Oncodesign Ally to Provide Oncology Drug Discovery Services
  
• Apogenix Obtains Roughly $3.66M to Further Cancer and Inflammatory Disease Initiatives
  
• ImmunoVaccine Technologies Collaborates with Scancell to Advance DNA Vaccine Delivery
  
• Horizon Gains Patents to Cell Lines that Model Genetic Mutations Seen in Cancer
  
• Vernalis Earns $6M Up Front in Oncology Deal with GSK
  
• Viral Genetics Forms Anticancer Subsidiary to Exploit Metabolic Disruption Technology
  
• Rosetta Genomics Taps Warnex as Canadian Distributor for Cancer Diagnostics
  
• Facet Biotech Steps Up to Help Trubion Advance Early-Stage Anticancer Agent with a $20M Fee
  
• Scientists Uncover Molecular Pathway that Makes Tumors More Aggressive
  
• BioMarker Strategies Secures $1.7M to Expedite Live Tumor Cell Testing System
  
• Access Pharma Taps Accupac to Manufacture Oral Mucositis Therapy in North America
  
• Qiagen Fortifies PCR-Based Solutions with Licenses from Roche and Idaho Technology
  
• Polish University to Use Cellectricon’s Transfection System
  
• imaGenes Becomes BioTrove’s OpenArray Service Provider